Bank of Montreal Can lowered its position in shares of Mettler-Toledo International Inc. (NYSE:MTD – Free Report) by 33.7% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 29,078 shares of the medical instruments supplier’s stock after selling 14,769 shares during the period. Bank of Montreal Can owned approximately 0.14% of Mettler-Toledo International worth $43,004,000 as of its most recent SEC filing.
Other hedge funds also recently made changes to their positions in the company. Family Firm Inc. purchased a new stake in shares of Mettler-Toledo International during the second quarter valued at approximately $25,000. Blue Trust Inc. grew its position in shares of Mettler-Toledo International by 242.9% during the third quarter. Blue Trust Inc. now owns 24 shares of the medical instruments supplier’s stock worth $34,000 after buying an additional 17 shares in the last quarter. Ashton Thomas Securities LLC acquired a new stake in shares of Mettler-Toledo International during the third quarter worth approximately $37,000. Rothschild Investment LLC acquired a new stake in shares of Mettler-Toledo International during the second quarter worth approximately $42,000. Finally, Itau Unibanco Holding S.A. acquired a new stake in shares of Mettler-Toledo International during the second quarter worth approximately $42,000. Hedge funds and other institutional investors own 95.07% of the company’s stock.
Insider Activity
In other news, Director Elisha W. Finney sold 76 shares of the business’s stock in a transaction on Monday, November 11th. The shares were sold at an average price of $1,311.75, for a total transaction of $99,693.00. Following the completion of the transaction, the director now owns 240 shares of the company’s stock, valued at approximately $314,820. The trade was a 24.05 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Corporate insiders own 1.94% of the company’s stock.
Mettler-Toledo International Price Performance
Mettler-Toledo International (NYSE:MTD – Get Free Report) last announced its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share (EPS) for the quarter, beating the consensus estimate of $10.00 by $0.21. Mettler-Toledo International had a net margin of 21.15% and a negative return on equity of 531.78%. The company had revenue of $954.54 million during the quarter, compared to the consensus estimate of $941.93 million. Equities research analysts anticipate that Mettler-Toledo International Inc. will post 40.39 earnings per share for the current year.
Analyst Upgrades and Downgrades
A number of analysts have recently weighed in on MTD shares. Wells Fargo & Company decreased their price target on shares of Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating for the company in a research report on Monday, November 11th. Evercore ISI raised their price target on shares of Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the stock an “in-line” rating in a research report on Tuesday, October 1st. Robert W. Baird decreased their price target on shares of Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating for the company in a research report on Monday, November 11th. Stifel Nicolaus decreased their price target on shares of Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating for the company in a research report on Monday, November 11th. Finally, JPMorgan Chase & Co. raised their price target on shares of Mettler-Toledo International from $1,300.00 to $1,400.00 and gave the stock a “neutral” rating in a research report on Monday, August 5th. Two equities research analysts have rated the stock with a sell rating, five have issued a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $1,338.75.
Check Out Our Latest Stock Analysis on Mettler-Toledo International
About Mettler-Toledo International
Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.
Featured Stories
- Five stocks we like better than Mettler-Toledo International
- What Investors Need to Know About Upcoming IPOs
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- How to invest in marijuana stocks in 7 stepsĀ
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- What Are Trending Stocks? Trending Stocks Explained
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Want to see what other hedge funds are holding MTD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mettler-Toledo International Inc. (NYSE:MTD – Free Report).
Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.